D
Portage Biotech Inc. PRTG
$5.42 -$0.54-9.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -31.79% -26.67% -47.96% 11.97% 5.48%
Depreciation & Amortization -23.08% -33.33% -53.33% -27.27% --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -54.60% -63.37% -72.90% -43.15% -18.01%
Operating Income 54.60% 63.37% 72.90% 43.15% 18.01%
Income Before Tax 92.46% 96.16% 77.57% 72.62% 77.23%
Income Tax Expenses -350.00% 99.97% -- 101.38% 100.01%
Earnings from Continuing Operations 92.47% 95.24% 73.63% 71.92% 73.62%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -97.92% -90.00% -71.43% 14.29% 242.86%
Net Income 92.46% 95.24% 73.63% 72.02% 73.65%
EBIT 54.60% 63.37% 72.90% 43.15% 18.01%
EBITDA 54.73% 63.48% 72.95% 43.19% 18.34%
EPS Basic 93.94% 96.18% 78.19% 76.40% 78.23%
Normalized Basic EPS -167.08% 77.14% 81.10% 71.88% 148.35%
EPS Diluted 93.94% 96.18% 78.21% 76.38% 78.23%
Normalized Diluted EPS -167.08% 77.14% 81.10% 71.88% 148.35%
Average Basic Shares Outstanding 24.33% 24.70% 20.90% 18.53% 21.02%
Average Diluted Shares Outstanding 24.33% 24.70% 20.90% 18.53% 21.02%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --